News

Michael Lutz, global manager of Cogenics, said: “Our partnership with SinoGenoMax provides us with an established presence in China and an experienced international service partner who operates with

Mr Altig is the CFO at Pelican Life Sciences, a manufacturer of microbiological and molecularbiological consumables. Mr Altig has also served as a director of Optimer Pharmaceuticals since

Through the agreement, Hitachi Medical will market, sell and service the Hi Art system, which facilitates highly precise, computed tomography-guided radiation therapy for a wide range of clinical

Under the umbrella of Alliance HealthCare Services, the company’s imaging and oncology divisions will continue to operate under the names of Alliance Imaging and Alliance Oncology. The company

APP’s rocuronium is AP-rated and preservative-free, and is marketed in two dosage forms, 50mg/5ml and 100mg/10ml. It is a nondepolarizing neuromuscular blocking agent that unlike other NMBA’s provides

The agreement grants Hamilton Thorne (HT) the exclusive rights to sell the confocal product to the regenerative medical research market that Hamilton Thorne serves worldwide. Current methods of

According to a new development and licensing agreement, RaySearch will develop software modules for Model-Based Segmentation (MBS) and treatment planning of Volumetric Modulated Arc Therapy (VMAT) for Oncentra

Dr Hixson currently serves as chairman of the board of Sequenom, a genetics and molecular diagnostic company. Dr Hixson is also a member of the board of Infinity

As part of the restructuring, Metabasis will focus on the company’s product candidates, MB07811 for the treatment of hyperlipidemia and MB07803 for the treatment of type 2 diabetes,